Can Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) cause epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, SSRIs and SNRIs can potentially cause nosebleeds in some individuals, as they can interfere with platelet aggregation and increase the risk of bleeding, including epistaxis, as noted in the study by 1. The medications, which include fluoxetine (Prozac), sertraline (Zoloft), venlafaxine (Effexor), and duloxetine (Cymbalta), affect serotonin levels in the body, and serotonin plays a role in blood clotting. The risk of nosebleeds is generally low, but it may be higher in people taking other medications that affect bleeding, such as aspirin, NSAIDs, or blood thinners, as mentioned in the study by 1. Some key points to consider:

  • SSRIs and SNRIs can increase the risk of bleeding, including nosebleeds, due to their effect on platelet aggregation, as reported in the study by 1.
  • The risk is generally low, but it may be higher in people taking other medications that affect bleeding, as noted in the study by 1.
  • If you experience frequent or severe nosebleeds while taking these medications, you should contact your healthcare provider, as recommended in the study by 1.
  • Your healthcare provider may recommend continuing the medication with monitoring if the nosebleeds are mild, adjusting the dosage, switching to a different antidepressant, or providing strategies to manage the nosebleeds, as suggested in the study by 1. It's essential to consult your healthcare provider before stopping or changing your medication, as abrupt discontinuation can cause withdrawal symptoms, as warned in the study by 1.

From the FDA Drug Label

Abnormal Bleeding — SSRIs and SNRIs, including fluoxetine, may increase the risk of bleeding events. ... Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages.

Abnormal Bleeding SSRIs and SNRIs, including venlafaxine HCl, may increase the risk of bleeding events Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anti-coagulants may add to this risk. ... Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages.

Abnormal Bleeding SSRIs and SNRIs, including sertraline, may increase the risk of bleeding events ranging from ecchymoses, hematomas, epistaxis, petechiae, and gastrointestinal hemorrhage to life-threatening hemorrhage.

Yes, SSRIs or SNRIs can cause nose bleeds, also known as epistaxis. This is due to the increased risk of bleeding events associated with these medications. Patients should be cautioned about the risk of bleeding associated with the concomitant use of SSRIs or SNRIs and NSAIDs, aspirin, or other drugs that affect coagulation 2, 3, 4.

From the Research

SSRI and SNRI Associated Adverse Effects

  • There is limited information on the specific adverse effect of nose bleeds associated with SSRI and SNRI use 5, 6, 7, 8, 9.
  • However, studies have reported various adverse effects associated with SSRI and SNRI use, including cutaneous adverse drug reactions (CADRs) 9.
  • A systematic review of case reports and case series found that SSRIs and SNRIs can cause CADRs, with females being more affected than males 9.
  • The review also found that the majority of reported CADRs were associated with SSRIs, particularly fluoxetine, sertraline, and paroxetine 9.
  • While nose bleeds are not specifically mentioned as an adverse effect in the provided studies, it is possible that they may be related to the vasoactive effects of certain medications on the nasal passages 5.

Vasoactive Effects of Medications

  • Drugs that affect the autonomic nervous system can have a vasoactive effect on the nose, potentially leading to nasal obstruction or other nasal symptoms 5.
  • However, there is no direct evidence in the provided studies to suggest that SSRIs or SNRIs can cause nose bleeds specifically 5, 6, 7, 8, 9.
  • Further research would be needed to determine the potential relationship between SSRI and SNRI use and the risk of nose bleeds.

Related Questions

What is the recommended dosage of Seroquel (quetiapine) when added to Effexor (venlafaxine) for depression treatment?
Is it acceptable for a physician to refill Selective Serotonin Reuptake Inhibitor (SSRI) medication for family members?
What are the recommended medications for treating anxiety?
What can be added to a patient's regimen of Effexor (venlafaxine) 337.5mg and Adderall XR (dextroamphetamine) 40mg daily for ongoing depressive symptoms?
Can a patient on sertraline (selective serotonin reuptake inhibitor) start duloxetine (serotonin-norepinephrine reuptake inhibitor) or venlafaxine (serotonin-norepinephrine reuptake inhibitor) for pain management?
What are the main factors to evaluate in pediatric patients for obstructive sleep apnea (OSA)?
What medication is recommended for nocturnal agitation in a hospital setting?
What is the diagnosis and treatment plan for a patient presenting with seizure, hyperglycemia, flank pain, elevated troponin levels, atrial fibrillation with rapid ventricular response, altered mental status, and newly diagnosed non-ST elevation myocardial infarction (NSTEMI), with a left ventricular ejection fraction (LVEF) of 45%, and being treated with aspirin and Plavix (clopidogrel), levofloxacin for a urinary tract infection (UTI), and metoprolol, while also being followed by nephrology for acute kidney injury (AKI)?
How to taper off Lunesta (Eszopiclone)?
What is the treatment for Staphylococcus (Staph) bacteremia?
Can albuterol (albuterol) be administered to a patient with hypertrophic cardiomyopathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.